Atlas Trials

A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

Clinical trial NCT04363372 · WITHDRAWN

Trial details

NCT number
NCT04363372
Sponsor
4D pharma plc
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-08-01
Primary completion
2020-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.